SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3,824.59 |
| Enterprise Value ($M) | 3,689.30 |
| Book Value ($M) | -266.41 |
| Book Value / Share | -2.23 |
| Price / Book | -14.36 |
| NCAV ($M) | -574.41 |
| NCAV / Share | -4.82 |
| Price / NCAV | -6.66 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.92 |
| Return on Assets (ROA) | -0.76 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.99 |
| Current Ratio | 5.99 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 956.05 |
| Assets | 1,264.05 |
| Liabilities | 1,530.46 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 18.47 |
| Operating Income | -536.25 |
| Net Income | -589.53 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -395.89 |
| Cash from Investing | -553.10 |
| Cash from Financing | 930.61 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | T. Rowe Price Investment Management, Inc. | 11.30 | 38.49 | |
| 13G/A | Fmr Llc | 9.40 | -10.22 | |
| 13G/A | Vanguard Group Inc | 10.09 | 1.31 | |
| 13G/A | BlackRock, Inc. | 13.00 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| Glossary of Terms | ||
| Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 166,841 | 804,568 | 20.74 | |
| 231,623 | 1,121,358 | 20.66 | |
| 233,497 | 1,012,803 | 23.05 | |
| 291,414 | 1,116,935 | 26.09 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CRGX – CARGO Therapeutics, Inc. | CRNX – Crinetics Pharmaceuticals, Inc. |
| CTMX – CytomX Therapeutics, Inc. | DAWN – Day One Biopharmaceuticals, Inc. |
| DNLI – Denali Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io